UnitedHealth Group Incorporated (NYSE:UNH) Shares Purchased by Missouri Trust & Investment Co

Missouri Trust & Investment Co increased its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 23.0% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 3,864 shares of the healthcare conglomerate’s stock after acquiring an additional 723 shares during the quarter. Missouri Trust & Investment Co’s holdings in UnitedHealth Group were worth $1,955,000 at the end of the most recent quarter.

Several other hedge funds have also made changes to their positions in UNH. Barlow Wealth Partners Inc. grew its stake in shares of UnitedHealth Group by 6.5% in the fourth quarter. Barlow Wealth Partners Inc. now owns 36,704 shares of the healthcare conglomerate’s stock worth $19,945,000 after purchasing an additional 2,250 shares in the last quarter. Traphagen Investment Advisors LLC raised its holdings in shares of UnitedHealth Group by 16.6% in the 4th quarter. Traphagen Investment Advisors LLC now owns 1,172 shares of the healthcare conglomerate’s stock worth $593,000 after purchasing an additional 167 shares in the last quarter. Genesis Private Wealth LLC bought a new stake in shares of UnitedHealth Group during the 4th quarter worth $240,000. MCF Advisors LLC raised its holdings in UnitedHealth Group by 0.8% during the 4th quarter. MCF Advisors LLC now owns 2,578 shares of the healthcare conglomerate’s stock worth $1,304,000 after buying an additional 20 shares during the period. Finally, Bourgeon Capital Management LLC lifted its position in shares of UnitedHealth Group by 13.4% in the 4th quarter. Bourgeon Capital Management LLC now owns 22,361 shares of the healthcare conglomerate’s stock valued at $11,312,000 after acquiring an additional 2,650 shares in the last quarter. Institutional investors own 87.86% of the company’s stock.

Wall Street Analyst Weigh In

A number of research analysts recently commented on the stock. Bank of America lowered their price objective on shares of UnitedHealth Group from $675.00 to $650.00 and set a “buy” rating on the stock in a research report on Wednesday, October 16th. Deutsche Bank Aktiengesellschaft upped their price objective on shares of UnitedHealth Group from $595.00 to $625.00 and gave the stock a “buy” rating in a report on Tuesday, December 3rd. Truist Financial dropped their price target on UnitedHealth Group from $625.00 to $610.00 and set a “buy” rating on the stock in a research report on Monday, January 6th. Morgan Stanley reduced their target price on shares of UnitedHealth Group from $615.00 to $610.00 and set an “overweight” rating for the company in a research note on Wednesday, October 16th. Finally, HSBC raised shares of UnitedHealth Group from a “hold” rating to a “buy” rating and set a $595.00 price target on the stock in a report on Friday, January 10th. One investment analyst has rated the stock with a hold rating, twenty have given a buy rating and two have assigned a strong buy rating to the company. According to data from MarketBeat.com, the stock has a consensus rating of “Buy” and a consensus price target of $627.74.

Insider Transactions at UnitedHealth Group

In other UnitedHealth Group news, Director Timothy Patrick Flynn purchased 1,000 shares of the firm’s stock in a transaction on Friday, January 17th. The shares were purchased at an average cost of $511.57 per share, with a total value of $511,570.00. Following the completion of the purchase, the director now owns 4,500 shares of the company’s stock, valued at $2,302,065. The trade was a 28.57 % increase in their position. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Insiders own 0.33% of the company’s stock.

UnitedHealth Group Stock Down 1.1 %

Shares of NYSE:UNH opened at $519.08 on Thursday. The firm has a market cap of $477.70 billion, a P/E ratio of 33.49, a PEG ratio of 1.42 and a beta of 0.62. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.91 and a current ratio of 0.83. UnitedHealth Group Incorporated has a 52-week low of $436.38 and a 52-week high of $630.73. The business’s 50 day simple moving average is $545.26 and its two-hundred day simple moving average is $564.10.

UnitedHealth Group (NYSE:UNH) last released its earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share (EPS) for the quarter, beating the consensus estimate of $6.74 by $0.07. The company had revenue of $100.81 billion during the quarter, compared to analyst estimates of $101.60 billion. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. UnitedHealth Group’s quarterly revenue was up 6.8% on a year-over-year basis. During the same period in the prior year, the company posted $5.83 earnings per share. As a group, research analysts forecast that UnitedHealth Group Incorporated will post 29.75 EPS for the current fiscal year.

UnitedHealth Group Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, December 17th. Investors of record on Monday, December 9th were issued a dividend of $2.10 per share. The ex-dividend date was Monday, December 9th. This represents a $8.40 dividend on an annualized basis and a yield of 1.62%. UnitedHealth Group’s dividend payout ratio (DPR) is 54.19%.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.